Penumbra Inc (PEN)

Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT

Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT PR Newswire ALAMEDA, Calif., June...

Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke

Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to...

Form SD - Specialized disclosure report

Form 4 - Statement of changes in beneficial ownership of securities

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Penumbra, Inc. Reports First Quarter 2026 Financial Results

Penumbra, Inc. Reports First Quarter 2026 Financial Results PR Newswire ALAMEDA, Calif., May 6, 2026...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations